Q1 2024 Theravance Biopharma Inc Earnings Call Transcript

May 13, 2024 / 09:00PM GMT
Operator

Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma first quarter 2024 conference call. (Operator instructions) Also, today's conference call is being recorded.

And now I would like to turn the call over to Rick Winningham, Chief Executive Officer. Please go ahead, sir.

Rick Winningham - Theravance Biopharma Inc - Chairman of the Board, Chief Executive Officer

Good afternoon, and welcome to Theravance Biopharma's first quarter 2024 earnings results conference call. On slide 2, you'll find our Safe Harbor language, and I'd remind everyone that our call today will include forward-looking statements involving risks and uncertainties pertaining to our development pipeline, expected benefits in our product candidate, anticipated timing of clinical trials, regulatory filings and expected financial results.

Information concerning factors that could cause results to differ materially from our forward-looking statements is described further in our filings with the SEC.

Now please turn to slide 3

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot